GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Seach Medical Group SEMG.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

257.50

-2.02%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Seach Medical Group

Its shares trade on Tel Aviv under the ticker SEMG.TA. It has been listed since 21 May 1990. In the fiscal year to 31 December 2025, it reported revenue of ILS 157.2m and net income of ILS 1.5m. At that date it held total assets of ILS 139.1m and shareholders' equity of ILS 89.2m.

Seach Medical Group Ltd. engages in propagation, cultivation, processing, production, marketing and distribution of cannabis products for medical use. The main acitivity of the Company is focused on cultivation, breeding, production and marketing of medical cannabis products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
21 May 1990
Website
seach.co.il ↗

Leadership

Pay as last reported

  • Mr. Nir ZichlinskeyChairman of the Board, since 2019
  • Mr. Yogev SaridChief Executive Officer, Director, since 2019
  • Mr. Shay SaridChief Technology Officer, Director, since 2019
  • Mr. Amichay RabVice President - Finance
  • Mr. Ofir SaridVice President
  • Ms. Shira Sitton DvorachekDirector of Human Resources
  • Ms. Margalit SaridManager of Growing Facility
  • Mr. Daniel SpiraInternal Auditor
  • Mr. Hagai ZachorBusiness Development Manager
  • Mr. Jacob AmidrorDirector
  • Samy BacklashDirector
  • Arnon SalomonDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company focuses on medical cannabis products including cultivation and marketing.
  • Operates in the pharmaceutical sector with a specific focus on medical cannabis.
  • Has been active since 1990 with an IPO date of May 21, 1990.

Weaknesses

  • City location is unknown, which may affect operational transparency.
  • Website is provided but lacks detailed information about operations.
  • Source description is untrusted and may not reflect accurate business activities.

Opportunities

  • Growing global demand for medical cannabis products presents market expansion potential.
  • Pharmaceutical sector growth could support increased market share for medical cannabis.
  • Potential for partnerships with healthcare providers in the medical cannabis space.

Threats

  • Regulatory challenges in the medical cannabis industry may impact operations.
  • Untrusted source description could lead to misinformation about the company.
  • Competition in the pharmaceutical sector may affect market positioning.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.